Koyfin Home > Directory > Health Care > Albireo Pharma Inc > EV / Sales (ntm)

Albireo Pharma Inc EV / Sales (ntm) Chart (ALBO)

Albireo Pharma Inc annual/quarterly EV / Sales (ntm) from 2017 to 2020.
  • Albireo Pharma Inc EV / Sales (ntm) for the quarter ending September 09, 2020 was 87.81 a -2.69% decrease of -2.36 year over year
  • Albireo Pharma Inc EV / Sales (ntm) for the last 12 months ending September 09, 2020 was 87.81 a -2.69% decrease of -2.36 year over year
  • Albireo Pharma Inc Annual EV / Sales (ntm) for 2020 was 87.81 a -0.47% decrease of -0.42 from 2019
  • Albireo Pharma Inc Annual EV / Sales (ntm) for 2020 was 88.23 a -2.49% decrease of -2.19 from 2019
  • Albireo Pharma Inc Annual EV / Sales (ntm) for 2020 was 90.42 a 0.28% increase of 0.25 from 2019
Other Valuation Metrics:
  • Albireo Pharma Inc Market Cap for the quarter ending March 03, 2018 was $387m a 54.85% increase of 213m year over year
  • Albireo Pharma Inc Price / Book for the quarter ending March 03, 2018 was 4.44 a 6.52% increase of 0.29 year over year
  • Albireo Pharma Inc Enterprise Value for the quarter ending March 03, 2018 was $334m a 52.94% increase of 177m year over year
View Chart On Koyfin

Quarterly ALBO EV / Sales (ntm) Data

09/202087.81
09/202088.23
09/202090.42
09/202090.17
09/202090.81
09/202086.64
09/202085.02
09/202089.25
09/202066.64
09/202039.80

Annual ALBO EV / Sales (ntm) Data

202087.81
202088.23
202090.42
202090.17
202090.81
202086.64
202085.02
202089.25
202066.64
202039.80